What is the official ID of this bill?

The official print number for this legislation is HR 1691.

When did the legislative process begin?

The process officially started on 2023-03-22.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/118/bills/hr1691/BILLS-118hr1691rh.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

Who is the primary sponsor?

The primary sponsor is Rep. Wenstrup, Brad R. [R-OH-2].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Placed on the Union Calendar, Calendar No. 801.

Analysis and Potential Impact of HR 1691

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Faster Access to Breakthrough Medical Devices in Medicare

Q: What are the main provisions?

Key points include: Establishes a 4-year transitional period for automatic Medicare coverage of breakthrough medical devices. Implements a fast-track approval process for new medical devices by the Secretary, with a 6-month decision deadline. Ensures national coverage decisions for innovative devices are made before the end of their transitional coverage period. Allocates $10 million annually for fiscal years 2025-2030 for program management and implementation.

This act aims to accelerate patient access to breakthrough medical devices under the Medicare program. This means new, innovative medical technologies will be available more quickly for individuals covered by Medicare, potentially improving their treatment and quality of life.

Key points

Establishes a 4-year transitional period for automatic Medicare coverage of breakthrough medical devices.

Implements a fast-track approval process for new medical devices by the Secretary, with a 6-month decision deadline.

Ensures national coverage decisions for innovative devices are made before the end of their transitional coverage period.

Allocates $10 million annually for fiscal years 2025-2030 for program management and implementation.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Print number: HR 1691

Sponsor: Rep. Wenstrup, Brad R. [R-OH-2]

Process start date: 2023-03-22

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch

Faster Access to Breakthrough Medical Devices in Medicare

Key Questions about Faster Access to Breakthrough Medical Devices in Medicare